Focus
immunotherapy
LATEST
Scientists Discover Molecule That Prevents Immune System From Attacking Cancer Cells
The findings offer potential for future research to improve the immune system’s response against cancers.
|
Common Immunotherapy Could Treat Heart Failure, Animal Study Finds
Scientists target scar tissue formation in a new heart failure treatment approach.
|
New Immunotherapy Boosts Hodgkin Lymphoma Survival Rate to 92 Percent
The treatment also showed a reduction in long-term side effects.
|
New Immunotherapy Shows Promise in Fighting Colon Cancer
NIH researchers achieve tumor shrinkage with new immunotherapy using engineered cells.
|
FDA Approves 1st T-Cell Therapy for Melanoma
The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.
|
Cancer Patients With Mutated Mitochondria Respond Better to Treatment
Mutated mitochondrial DNA is common among cancer patients, and luckily, it may provide a way to bolster treatment.
|
Scientists Discover Molecule That Prevents Immune System From Attacking Cancer Cells
The findings offer potential for future research to improve the immune system’s response against cancers.
|
Common Immunotherapy Could Treat Heart Failure, Animal Study Finds
Scientists target scar tissue formation in a new heart failure treatment approach.
|
New Immunotherapy Boosts Hodgkin Lymphoma Survival Rate to 92 Percent
The treatment also showed a reduction in long-term side effects.
|
New Immunotherapy Shows Promise in Fighting Colon Cancer
NIH researchers achieve tumor shrinkage with new immunotherapy using engineered cells.
|
FDA Approves 1st T-Cell Therapy for Melanoma
The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.
|
Cancer Patients With Mutated Mitochondria Respond Better to Treatment
Mutated mitochondrial DNA is common among cancer patients, and luckily, it may provide a way to bolster treatment.
|